Casual restaurant chain Brinker International (NYSE:EAT) announced better-than-expected revenue in Q1 CY2025, with sales up 27.2% year on year to $1.43 billion. The company’s full-year revenue guidance of $5.34 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $2.66 per share was 3.6% above analysts’ consensus estimates.
Enterprise data capture company Zebra Technologies (NASDAQ:ZBRA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.3% year on year to $1.31 billion. The company expects next quarter’s revenue to be around $1.28 billion, close to analysts’ estimates. Its non-GAAP profit of $4.02 per share was 11.1% above analysts’ consensus estimates.
The VIX fear index has declined 22% in the last five days — suggesting that investors are expecting less drama in front of them than they have behind.
Biotech company Regeneron (NASDAQ:REGN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.7% year on year to $3.03 billion. Its non-GAAP profit of $8.22 per share was 3% below analysts’ consensus estimates.
Industrial conglomerate Honeywell (NASDAQ:HON) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.9% year on year to $9.82 billion. On the other hand, the company’s full-year revenue guidance of $40.05 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $2.51 per share was 13.6% above analysts’ consensus estimates.
Money market account interest rates today are still well above historical norms. Find out where to get the best money market account rates now.
(Reuters) -China, the world's biggest pork consumer, is no longer a viable market for top U.S. pork processor Smithfield Foods due to retaliatory tariffs by Beijing, company executives said on Tuesday. The sales disruption shows how the tariff war escalated by U.S. President Donald Trump is upending global trade and forcing changes at a prominent food company that pays U.S. farmers to raise hogs that are slaughtered for meat. China increased its levies on imports of U.S. goods this month, hitting back at Trump's decision to single out the world's No. 2 economy for higher duties.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and the rest of the healthcare technology for providers stocks fared in Q4.
Over the last six months, Jacobs Solutions shares have sunk to $123.15, producing a disappointing 13.8% loss - worse than the S&P 500’s 5% drop. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Lamb Weston’s stock price has taken a beating over the past six months, shedding 33.1% of its value and falling to $51.75 per share. This may have investors wondering how to approach the situation.